Literature DB >> 23558486

Mild cognitive impairment.

Oscar L Lopez1.   

Abstract

PURPOSE OF REVIEW: The term mild cognitive impairment (MCI) is used to describe older subjects with demonstrable cognitive impairment who have not crossed the threshold for dementia. Because patients with MCI have an increased risk of developing dementia, especially Alzheimer disease (AD), there is significant interest in the clinical characterization of these subjects and in understanding the pathophysiology of the transition from MCI to AD. RECENT
FINDINGS: The MCI syndrome, as an expression of an incipient disorder that may lead to dementia, is extremely heterogeneous and may coexist with systemic, neurologic, or psychiatric disorders that can cause cognitive deficits. Recent clinical criteria were designed to take into account the different forms of clinical presentation of the syndrome, and introduced the possible contribution of biomarkers to the clinical diagnosis. Bedside diagnosis of MCI can be difficult, since patients who report having cognitive problems may have normal scores in global cognitive scales or in brief neuropsychological instruments.
SUMMARY: This article presents the evolution of the clinical concept of MCI, the operationalization of its current definitions, the development of biomarkers that can help to identify an underlying neurodegenerative process as the etiology of the syndrome, and its proposed treatments.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23558486      PMCID: PMC3915547          DOI: 10.1212/01.CON.0000429175.29601.97

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  80 in total

1.  Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

Authors:  G Chételat; B Desgranges; V de la Sayette; F Viader; F Eustache; J-C Baron
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

2.  Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study.

Authors:  K I Erickson; C A Raji; O L Lopez; J T Becker; C Rosano; A B Newman; H M Gach; P M Thompson; A J Ho; L H Kuller
Journal:  Neurology       Date:  2010-10-13       Impact factor: 9.910

3.  Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study.

Authors:  C DeCarli; B L Miller; G E Swan; T Reed; P A Wolf; D Carmelli
Journal:  Arch Neurol       Date:  2001-04

4.  Cognitive markers preceding Alzheimer's dementia in the healthy oldest old.

Authors:  D B Howieson; A Dame; R Camicioli; G Sexton; H Payami; J A Kaye
Journal:  J Am Geriatr Soc       Date:  1997-05       Impact factor: 5.562

5.  Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study.

Authors:  Oscar L Lopez; Lewis H Kuller; James T Becker; Corinne Dulberg; Robert A Sweet; H Michael Gach; Steven T Dekosky
Journal:  Arch Neurol       Date:  2007-03

6.  Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging.

Authors:  Gaël Chetelat; Jean-Claude Baron
Journal:  Neuroimage       Date:  2003-02       Impact factor: 6.556

7.  Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly.

Authors:  Hwamee Oh; Christian Habeck; Cindee Madison; William Jagust
Journal:  Hum Brain Mapp       Date:  2012-09-11       Impact factor: 5.038

8.  Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial.

Authors:  C G Lyketsos; J C S Breitner; R C Green; B K Martin; C Meinert; S Piantadosi; M Sabbagh
Journal:  Neurology       Date:  2007-04-25       Impact factor: 9.910

9.  Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study.

Authors:  Beth E Snitz; Judith Saxton; Oscar L Lopez; Diane G Ives; Leslie O Dunn; Stephen R Rapp; Michelle C Carlson; Annette L Fitzpatrick; Steven T Dekosky
Journal:  Aging Ment Health       Date:  2009-03       Impact factor: 3.658

10.  Donepezil delays progression to AD in MCI subjects with depressive symptoms.

Authors:  P H Lu; S D Edland; E Teng; K Tingus; R C Petersen; J L Cummings
Journal:  Neurology       Date:  2009-06-16       Impact factor: 9.910

View more
  9 in total

1.  An Exploratory Study of Mild Cognitive Impairment of Retired Professional Contact Sport Athletes.

Authors:  John G Baker; John J Leddy; Andrea L Hinds; Mohammad N Haider; Jennifer Shucard; Tania Sharma; Sergio Hernandez; Joel Durinka; Robert Zivadinov; Barry S Willer
Journal:  J Head Trauma Rehabil       Date:  2018 Sep/Oct       Impact factor: 2.710

2.  Disrupted functional connectivity between perirhinal and parahippocampal cortices with hippocampal subfields in patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Yu Sun; Yafei Wang; Jiaming Lu; Rengyuan Liu; Christopher G Schwarz; Hui Zhao; Yue Zhang; Lingyi Xu; Bin Zhu; Bing Zhang; Bing Liu; Suiren Wan; Yun Xu
Journal:  Oncotarget       Date:  2017-05-16

3.  Different Associations of Plasma Biomarkers in Alzheimer's Disease, Mild Cognitive Impairment, Vascular Dementia, and Ischemic Stroke.

Authors:  Jingwei Shang; Toru Yamashita; Yusuke Fukui; Dongjing Song; Xianghong Li; Yun Zhai; Yumiko Nakano; Ryuta Morihara; Nozomi Hishikawa; Yasuyuki Ohta; Koji Abe
Journal:  J Clin Neurol       Date:  2018-01       Impact factor: 3.077

4.  Combining SPECT and Quantitative EEG Analysis for the Automated Differential Diagnosis of Disorders with Amnestic Symptoms.

Authors:  Yvonne Höller; Arne C Bathke; Andreas Uhl; Nicolas Strobl; Adelheid Lang; Jürgen Bergmann; Raffaele Nardone; Fabio Rossini; Harald Zauner; Margarita Kirschner; Amirhossein Jahanbekam; Eugen Trinka; Wolfgang Staffen
Journal:  Front Aging Neurosci       Date:  2017-09-07       Impact factor: 5.750

5.  The efficacy of cognitive interventions on the performance of instrumental activities of daily living in individuals with mild cognitive impairment or mild dementia: protocol for a systematic review and meta-analysis.

Authors:  Nikki Tulliani; Michelle Bissett; Rosalind Bye; Katrina Chaudhary; Paul Fahey; Karen P Y Liu
Journal:  Syst Rev       Date:  2019-08-28

Review 6.  Lights and Shadows in Hepatic Encephalopathy Diagnosis.

Authors:  Piero Amodio; Sara Montagnese
Journal:  J Clin Med       Date:  2021-01-18       Impact factor: 4.241

7.  Hippocampal volume and hippocampal angle (a more practical marker) in mild cognitive impairment: A case-control magnetic resonance imaging study.

Authors:  Reza Basiratnia; Ehsan Amini; Mohammad Reza Sharbafchi; Mohammad Maracy; Majid Barekatain
Journal:  Adv Biomed Res       Date:  2015-09-28

8.  Problems in Classifying Mild Cognitive Impairment (MCI): One or Multiple Syndromes?

Authors:  María Del Carmen Díaz-Mardomingo; Sara García-Herranz; Raquel Rodríguez-Fernández; César Venero; Herminia Peraita
Journal:  Brain Sci       Date:  2017-09-01

9.  Methylglyoxal and Glyoxal as Potential Peripheral Markers for MCI Diagnosis and Their Effects on the Expression of Neurotrophic, Inflammatory and Neurodegenerative Factors in Neurons and in Neuronal Derived-Extracellular Vesicles.

Authors:  Mohamed Haddad; Morgane Perrotte; Mohamed Raâfet Ben Khedher; Clément Demongin; Aurélie Lepage; Tamás Fülöp; Charles Ramassamy
Journal:  Int J Mol Sci       Date:  2019-10-03       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.